214 related articles for article (PubMed ID: 16850267)
1. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model.
Feng Y; Zong Y; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Aug; 23(8):1736-42. PubMed ID: 16850267
[TBL] [Abstract][Full Text] [Related]
2. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
[TBL] [Abstract][Full Text] [Related]
3. Effect of size and charge on pharmacokinetics and in vivo MRI contrast enhancement of biodegradable polydisulfide Gd(III) complexes.
Zong Y; Guo J; Ke T; Mohs AM; Parker DL; Lu ZR
J Control Release; 2006 May; 112(3):350-6. PubMed ID: 16631270
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced MRI with new biodegradable macromolecular Gd(III) complexes in tumor-bearing mice.
Zong Y; Wang X; Goodrich KC; Mohs AM; Parker DL; Lu ZR
Magn Reson Med; 2005 Apr; 53(4):835-42. PubMed ID: 15799038
[TBL] [Abstract][Full Text] [Related]
5. Modification of Gd-DTPA cystine copolymers with PEG-1000 optimizes pharmacokinetics and tissue retention for magnetic resonance angiography.
Mohs AM; Nguyen T; Jeong EK; Feng Y; Emerson L; Zong Y; Parker DL; Lu ZR
Magn Reson Med; 2007 Jul; 58(1):110-118. PubMed ID: 17659618
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
Wang X; Feng Y; Ke T; Schabel M; Lu ZR
Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
[TBL] [Abstract][Full Text] [Related]
7. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
[TBL] [Abstract][Full Text] [Related]
8. PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.
Mohs AM; Zong Y; Guo J; Parker DL; Lu ZR
Biomacromolecules; 2005; 6(4):2305-11. PubMed ID: 16004476
[TBL] [Abstract][Full Text] [Related]
9. Extracellular biodegradable macromolecular gadolinium(III) complexes for MRI.
Lu ZR; Parker DL; Goodrich KC; Wang X; Dalle JG; Buswell HR
Magn Reson Med; 2004 Jan; 51(1):27-34. PubMed ID: 14705042
[TBL] [Abstract][Full Text] [Related]
10. PEG-g-poly(GdDTPA-co-L-cystine): a biodegradable macromolecular blood pool contrast agent for MR imaging.
Mohs AM; Wang X; Goodrich KC; Zong Y; Parker DL; Lu ZR
Bioconjug Chem; 2004; 15(6):1424-30. PubMed ID: 15546211
[TBL] [Abstract][Full Text] [Related]
11. Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.
Feng Y; Jeong EK; Mohs AM; Emerson L; Lu ZR
Magn Reson Med; 2008 Dec; 60(6):1347-52. PubMed ID: 19025902
[TBL] [Abstract][Full Text] [Related]
12. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
13. Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice.
Wu X; Feng Y; Jeong EK; Emerson L; Lu ZR
Pharm Res; 2009 Sep; 26(9):2202-8. PubMed ID: 19597972
[TBL] [Abstract][Full Text] [Related]
14. A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox-sensitive biodegradable macromolecular MRI contrast agent.
Ye Z; Zhou Z; Ayat N; Wu X; Jin E; Shi X; Lu ZR
Contrast Media Mol Imaging; 2016; 11(1):32-40. PubMed ID: 26218648
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-containing copolymeric chelates--a new potential MR contrast agent.
Unger EC; Shen D; Wu G; Stewart L; Matsunaga TO; Trouard TP
MAGMA; 1999 Aug; 8(3):154-62. PubMed ID: 10504042
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity.
Parac-Vogt TN; Vander Elst L; Kimpe K; Laurent S; Burtéa C; Chen F; Van Deun R; Ni Y; Muller RN; Binnemans K
Contrast Media Mol Imaging; 2006; 1(6):267-78. PubMed ID: 17191767
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]